Home › Hypertrophic Cardiomyopathy › Virginia
Hypertrophic Cardiomyopathy clinical trials in Virginia
4 studies for Hypertrophic Cardiomyopathy are looking for participants at sites in Virginia.
Cities in Virginia
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
- The Rector and Visitors of the Univ of Virginia, Charlottesville
- VCU Medical Center, Richmond
- Carilion Clinic; Virginia Tech-Carilion School of Medicine, Roanoke
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 19, 2026 · NCT05489705A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy
- Imbria Investigational Site, Charlottesville
- Imbria Investigational Site, Richmond
RecruitingPhase 2
Ages 18 and older · All sexes · Updated May 18, 2026 · NCT07023614HCMR Re-Imaging Study
- University of Virginia, Charlottesville
RecruitingObservational study
Ages 18 to 65 · All sexes · Updated Mar 18, 2026 · NCT07054073Effect of Mavacamten Treatment on Coronary Flow Reserve in oHCM
- University of Virginia, Charlottesville
RecruitingObservational study
Ages 18 to 85 · All sexes · Updated Nov 6, 2024 · NCT06023186From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.